Items where the Publication is EUROPEAN HEART JOURNAL

Year Authors/Creators Item Type Full Text

Public

'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies. (2018) Annemans, Lieven; Packard, Chris J; Briggs, Andrew; Ray, Kausik K

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. (2021) Cleland, John GF; Ferreira, João Pedro; Mariottoni, Beatrice; Pellicori, Pierpaolo; Cuthbert, Joe; Verdonschot, Job AJ; Petutschnigg, Johannes; Ahmed, Fozia Z; Cosmi, Franco; Brunner La Rocca, Hans-Peter; Mamas, Mamas A; Clark, Andrew L; Edelmann, Frank; Pieske, Burkert; Khan, Javed; McDonald, Ken; Rouet, Philippe; Staessen, Jan A; Mujaj, Blerim; González, Arantxa; Diez, Javier; Hazebroek, Mark; Heymans, Stephane; Latini, Roberto; Grojean, Stéphanie; Pizard, Anne; Girerd, Nicolas; Rossignol, Patrick; Collier, Tim J; Zannad, Faiez; HOMAGE Trial Committees and Investigators

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. (2010) Komajda, Michel; McMurray, John JV; Beck-Nielsen, Henning; Gomis, Ramon; Hanefeld, Markolf; Pocock, Stuart J; Curtis, Paula S; Jones, Nigel P; Home, Philip D